Halozyme Therapeutics shares owned by Fox Run Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Fox Run Management
from 13F filings
Historical chart of Fox Run Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Fox Run Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Fox Run Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $903k | 12k | 73.34 |
| 2025-06-30 | $844k | 16k | 52.02 |
| 2024-12-31 | $489k | 10k | 47.81 |
| 2024-06-30 | $262k | 5.0k | 52.36 |
| 2024-03-31 | $685k | 17k | 40.68 |
| 2023-09-30 | $669k | 18k | 38.20 |
| 2022-06-30 | $336k | 7.6k | 43.98 |
| 2018-12-31 | $151k | 10k | 14.64 |
| 2018-09-30 | $326k | 18k | 18.15 |
| 2018-03-31 | $243k | 12k | 19.55 |
| 2017-12-31 | $777k | 38k | 20.26 |
| 2017-09-30 | $294k | 17k | 17.40 |